Day: July 23, 2021

CRMD – CRMD ALERT: Investors With Substantial Losses Have Opportunity to Lead the CorMedix Inc. Class Action Lawsuit

SAN DIEGO–()–Robbins Geller Rudman & Dowd LLP announces that purchasers of CorMedix Inc. (NASDAQ: CRMD) securities between July 8, 2020 and May 13, 2021, inclusive (“Class Period”) have until September 20, 2021 to seek appointment as lead plaintiff in the CorMedix class action lawsuit. The CorMedix class action lawsuit charges CorMedix and certain of its top executives with violations of the Securities Exchange Act of 1934. The CorMedix class action lawsuit was commenced on July 22, 2021 in the District of New Jersey and is captioned Patrick v. CorMedix Inc., No. 21-cv-14020.

If you wish to serve as lead plaintiff of the CorMedix class action lawsuit, please provide your information by clicking here. You can also contact attorney J.C. Sanchez of Robbins Geller by calling 800/449-4900 or via e-mail at jsanchez@rgrdlaw.com. Lead plaintiff motions for the CorMedix class action lawsuit must be filed with the court no later than September 20, 2021.

CASE ALLEGATIONS: The CorMedix class action lawsuit alleges that, throughout the Class Period, defendants made false and misleading statements and failed to disclose that: (i) deficiencies existed with respect to CorMedix’s lead product candidate DefenCath’s manufacturing process and/or at the facility responsible for manufacturing DefenCath; (ii) in light of the foregoing deficiencies, the U.S. Food and Drug Administration (“FDA”) was unlikely to approve the DefenCath New Drug Application (“NDA”) for catheter-related bloodstream infections in its present form; (iii) defendants had downplayed the true scope of the deficiencies with DefenCath’s manufacturing process and/or at the facility responsible for manufacturing DefenCath; and (iv) as a result, CorMedix’s public statements were materially false and misleading at all relevant times.

On March 1, 2021, CorMedix issued a press release “announc[ing] that the [FDA] cannot approve the [NDA] for DefenCath . . . in its present form.” CorMedix informed investors that the “FDA noted concerns at the third-party manufacturing facility after a review of records requested by FDA and provided by the manufacturing facility”; that the “FDA did not specify the issues and CorMedix intends to work with the manufacturing facility to develop a plan for resolution when FDA informs the facility of the specific concerns”; that, “[w]hen we are informed of the issues, we will schedule an investor conference call to provide an update on our expected timeline for resolution”; and that “[a]dditionally, FDA is requiring a manual extraction study to demonstrate that the labeled volume can be consistently withdrawn from the vials despite an existing in-process control to demonstrate fill volume within specifications.” On this news, CorMedix’s stock price fell nearly 40%.

Then, on April 14, 2021, CorMedix announced that it would have to take additional steps to meet the FDA’s requirements for DefenCath’s manufacturing process, including “[a]ddressing [the] FDA’s concerns regarding the qualification of the filling operation [that] may necessitate adjustments in the process and generation of additional data on operating parameters for manufacture of DefenCath.” On this news, CorMedix’s stock price fell more than 15%.

Finally, on May 13, 2021, CorMedix announced that “[b]ased on our analyses, we have concluded that additional process qualification will be needed with subsequent validation to address the deficiencies identified by [the] FDA.” After an analyst pressed for clearer information on DefenCath’s manufacturing deficiencies on a conference call held that same day, CorMedix’s Executive Vice President and General Counsel, defendant Phoebe Mounts, disclosed among other things that “there are times when there may be unexpected results obtained”; that the FDA “expect[s] us to generate sufficient data to demonstrate that [the filling] process is a controlled process and is consistent with the agency’s requirements for good manufacturing practice”; that “sterility is a very important part of that process,” as well as “the accuracy in making sure the right volume of DefenCath is loaded into the vials”; that “we’re talking about thousands of vials during the manufacturing run”; that CorMedix must “generat[e] a lot of data to make sure that . . . all the equipment has been qualified for the intended use and every step in the manufacturing process has been qualified”; that “th[e] process needs to be very robust, [and] needs to be reproducible”; and that “the burden is on the manufacturer to demonstrate that the facility can do that process reducibly and generate the required product for commercial distribution.” On this news, CorMedix’s stock price fell an additional 20%, further damaging investors.

THE LEAD PLAINTIFF PROCESS: The Private Securities Litigation Reform Act of 1995 permits any investor who purchased CorMedix securities during the Class Period to seek appointment as lead plaintiff in the CorMedix class action lawsuit. A lead plaintiff is generally the movant with the greatest financial interest in the relief sought by the putative class who is also typical and adequate of the putative class. A lead plaintiff acts on behalf of all other class members in directing the CorMedix class action lawsuit. The lead plaintiff can select a law firm of its choice to litigate the CorMedix class action lawsuit. An investor’s ability to share in any potential future recovery of the CorMedix class action lawsuit is not dependent upon serving as lead plaintiff.

ABOUT ROBBINS GELLER RUDMAN & DOWD LLP: With 200 lawyers in 9 offices nationwide, Robbins Geller Rudman & Dowd LLP is the largest U.S. law firm representing investors in securities class actions. Robbins Geller attorneys have obtained many of the largest shareholder recoveries in history, including the largest securities class action recovery ever – $7.2 billion – in In re Enron Corp. Sec. Litig. The 2020 ISS Securities Class Action Services Top 50 Report ranked Robbins Geller first for recovering $1.6 billion for investors last year, more than double the amount recovered by any other securities plaintiffs’ firm. Please visit https://www.rgrdlaw.com/firm.html for more information.

Attorney advertising.

Past results do not guarantee future outcomes.

Services may be performed by attorneys in any of our offices.

TOGL – Toga Limited's Majority Owned Subsidiary Eostre Berhad is Appointed as the E-commerce Platform Provider for Hayes Products by Vicex PLT

PETALING JAYA, Malaysia, July 23, 2021 (GLOBE NEWSWIRE) — Toga Limited’s (OTC: TOGL) Majority Owned Subsidiary Eostre Berhad, has been officially appointed by Vicex PLT as its e-commerce online crossover platform provider to exclusively sell Hayes products to members of both companies. Eostre is now tasked with providing the platform with the URL, “int.eostre.biz”, as the e-commerce online crossover platform.

“We are pleased to establish this collaboration between Vicex and Eostre. This collaboration will further grow Eostre’s product range and customer base globally,” said Eostre Berhad General Manager, Ms. Low Kah Fong.

“We anticipate both companies will jointly expand the awareness and demand for the Hayes range of premium sanitary napkins. This is also seen as being in line with Eostre’s vision of becoming an international brand with world-leading innovative healthcare products,” said Ms. Low.

Contact:

Alexander D. Henderson
TOGA LIMITED, 515 S. Flower Street, 18th Floor, Los Angeles, CA 90071
(949) 333-1603
info@togalimited.com

Certain statements in this press release are forward-looking as defined in the Private Securities Litigation Reform Act of 1995. Any statements contained herein that are not statements of historical fact (including, but not limited to, statements to the effect that Toga Limited or its management (the “Company”) “anticipates,” “plans,” “estimates,” “expects,” or “believes,” or the negative of these terms and other similar expressions) should be considered forward-looking statements, including, without limitation, statements regarding the Company’s guidance, outlook, growth, opportunities and long-term strategy. These statements involve certain risks and uncertainties that may cause actual results to differ materially from expectations as of the date of this release. These risks and uncertainties include, without limitation, risks associated with the impact of the COVID-19 pandemic; the Company’s ability to execute on its long-term strategy; the Company’s ability to successfully compete in its intensely competitive industry; the Company’s ability to manage its growth; the Company’s ability to maintain or improve its operating margins; the Company’s ability to identify and react to trends in consumer preferences; product supply disruptions; general economic conditions; accounting standard changes; and other factors as set forth from time to time in the Company’s Securities and Exchange Commission filings, including, without limitation, the Company’s Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. The Company intends these forward-looking statements to speak only as of the time of this Press Release and does not undertake to update or revise them as more information becomes available, except as required by law.

CROX – Pro: Crocs is a stock ‘you shouldn't underestimate'

Footwear brand Crocs, Inc. (NASDAQ: CROX) stock has gained 260% in the last 12 months. The stock emerged as a true winner in the retail space, and underestimating the stock’s performance should not be done, according to one investment pro.

Revenue nearly doubled 

Thanks to the demand for footwear, Crocs stock price picked up momentum. The company reported its quarterly earnings on Thursday, and the stock soared, adding 10% after declaring earnings. The good news is that the footwear company’s revenue nearly doubled compared to last year’s earnings. According to reports, 60% sales growth is estimated in the on-going quarter.


Are you looking for fast-news, hot-tips and market analysis?

Sign-up for the Invezz newsletter, today.

In an interview on CNBC’s “Trading Nation” on Thursday, Chantico Global CEO Gina Sanchez said:

“They are so cheap relative to other retailers, particularly footwear. They’re trading at 20 times forward PE, 22 times trailing which is to say that they’re expecting great growth, and that growth is not yet priced into the stock.”

In the same interview, calling it an interesting stock, she reiterated not to “underestimate this stock.”

According to reports, the stock is expected to register a $5.80 share profit for the year, 80% higher than last year.

Crocs, Inc. stock doing well post-pandemic

Crocs stock is beyond any doubt doing well after the pandemic. Seconding this opinion is President of Blue Line Capital Bill Baruch, who said:

“The company has done everything right – everything from celebrity sponsors, they’ve done a great e-commerce pivot during the pandemic and another great earnings report here with accelerating growth. I do think that there is a place to buy here. I’m looking at the technicals.”

According to him, the best time to add this stock to your portfolio will be when the stock value falls as low as $92. Crocs, Inc.’s stock closed at $131.93 on Thursday.

Invest in crypto, stocks, ETFs & more in minutes with our preferred broker,

eToro






10/10

67% of retail CFD accounts lose money

AXL – American Axle & Manufacturing (AXL) Outpaces Stock Market Gains: What You Should Know

American Axle & Manufacturing (AXL Free Report) closed the most recent trading day at $9.37, moving +1.63% from the previous trading session. The stock outpaced the S&P 500’s daily gain of 1.02%.

Prior to today’s trading, shares of the maker of auto parts had lost 16.86% over the past month. This has lagged the Auto-Tires-Trucks sector’s loss of 1.33% and the S&P 500’s gain of 3.01% in that time.

Investors will be hoping for strength from AXL as it approaches its next earnings release, which is expected to be July 30, 2021. In that report, analysts expect AXL to post earnings of $0.01 per share. This would mark year-over-year growth of 100.56%. Our most recent consensus estimate is calling for quarterly revenue of $1.19 billion, up 130.47% from the year-ago period.

AXL’s full-year Zacks Consensus Estimates are calling for earnings of $1.49 per share and revenue of $5.54 billion. These results would represent year-over-year changes of +964.29% and +17.53%, respectively.

Investors should also note any recent changes to analyst estimates for AXL. These recent revisions tend to reflect the evolving nature of short-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the company’s business outlook.

Research indicates that these estimate revisions are directly correlated with near-term share price momentum. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.

The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection has moved 0.68% higher. AXL is currently a Zacks Rank #3 (Hold).

Valuation is also important, so investors should note that AXL has a Forward P/E ratio of 6.2 right now. Its industry sports an average Forward P/E of 12.32, so we one might conclude that AXL is trading at a discount comparatively.

Also, we should mention that AXL has a PEG ratio of 0.77. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company’s expected earnings growth rate. The Automotive – Original Equipment was holding an average PEG ratio of 0.85 at yesterday’s closing price.

The Automotive – Original Equipment industry is part of the Auto-Tires-Trucks sector. This group has a Zacks Industry Rank of 175, putting it in the bottom 32% of all 250+ industries.

The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

You can find more information on all of these metrics, and much more, on Zacks.com.

GE – General Electric (GE) Gains But Lags Market: What You Should Know

General Electric (GE Free Report) closed the most recent trading day at $12.71, moving +0.08% from the previous trading session. This move lagged the S&P 500’s daily gain of 1.02%.

Prior to today’s trading, shares of the industrial conglomerate had lost 3.42% over the past month. This has lagged the Conglomerates sector’s gain of 4.62% and the S&P 500’s gain of 3.01% in that time.

Wall Street will be looking for positivity from GE as it approaches its next earnings report date. This is expected to be July 27, 2021. On that day, GE is projected to report earnings of $0.03 per share, which would represent year-over-year growth of 120%. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $18.27 billion, up 2.95% from the year-ago period.

For the full year, our Zacks Consensus Estimates are projecting earnings of $0.25 per share and revenue of $77.82 billion, which would represent changes of +2400% and -2.26%, respectively, from the prior year.

Investors should also note any recent changes to analyst estimates for GE. These revisions typically reflect the latest short-term business trends, which can change frequently. As such, positive estimate revisions reflect analyst optimism about the company’s business and profitability.

Based on our research, we believe these estimate revisions are directly related to near-team stock moves. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.

The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. The Zacks Consensus EPS estimate has moved 2.36% lower within the past month. GE is holding a Zacks Rank of #4 (Sell) right now.

Valuation is also important, so investors should note that GE has a Forward P/E ratio of 50.51 right now. Its industry sports an average Forward P/E of 20.56, so we one might conclude that GE is trading at a premium comparatively.

It is also worth noting that GE currently has a PEG ratio of 11.88. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock’s expected earnings growth rate. Diversified Operations stocks are, on average, holding a PEG ratio of 1.8 based on yesterday’s closing prices.

The Diversified Operations industry is part of the Conglomerates sector. This group has a Zacks Industry Rank of 57, putting it in the top 23% of all 250+ industries.

The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

You can find more information on all of these metrics, and much more, on Zacks.com.

DDS – Dillard's (DDS) Stock Sinks As Market Gains: What You Should Know

In the latest trading session, Dillard’s (DDS Free Report) closed at $182.26, marking a -1.53% move from the previous day. This move lagged the S&P 500’s daily gain of 1.02%.

Coming into today, shares of the department store operator had gained 1.21% in the past month. In that same time, the Retail-Wholesale sector gained 0.19%, while the S&P 500 gained 3.01%.

Investors will be hoping for strength from DDS as it approaches its next earnings release. On that day, DDS is projected to report earnings of $2.45 per share, which would represent year-over-year growth of 762.16%. Meanwhile, our latest consensus estimate is calling for revenue of $1.26 billion, up 36.89% from the prior-year quarter.

Looking at the full year, our Zacks Consensus Estimates suggest analysts are expecting earnings of $15.17 per share and revenue of $5.82 billion. These totals would mark changes of +655.68% and +35.21%, respectively, from last year.

It is also important to note the recent changes to analyst estimates for DDS. These recent revisions tend to reflect the evolving nature of short-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the company’s business outlook.

Our research shows that these estimate changes are directly correlated with near-term stock prices. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.

Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Within the past 30 days, our consensus EPS projection remained stagnant. DDS is currently a Zacks Rank #3 (Hold).

Looking at its valuation, DDS is holding a Forward P/E ratio of 12.21. This valuation marks a premium compared to its industry’s average Forward P/E of 11.88.

We can also see that DDS currently has a PEG ratio of 0.5. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company’s expected earnings growth rate. Retail – Regional Department Stores stocks are, on average, holding a PEG ratio of 0.66 based on yesterday’s closing prices.

The Retail – Regional Department Stores industry is part of the Retail-Wholesale sector. This group has a Zacks Industry Rank of 110, putting it in the top 44% of all 250+ industries.

The Zacks Industry Rank includes is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

To follow DDS in the coming trading sessions, be sure to utilize Zacks.com.

DKNG – DraftKings (DKNG) Gains But Lags Market: What You Should Know

DraftKings (DKNG Free Report) closed at $49.33 in the latest trading session, marking a +0.18% move from the prior day. This move lagged the S&P 500’s daily gain of 1.02%.

Coming into today, shares of the company had lost 3.56% in the past month. In that same time, the Consumer Discretionary sector lost 2.13%, while the S&P 500 gained 3.01%.

Investors will be hoping for strength from DKNG as it approaches its next earnings release, which is expected to be August 6, 2021. In that report, analysts expect DKNG to post earnings of -$0.61 per share. This would mark a year-over-year decline of 177.27%. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $240.84 million, up 239.55% from the year-ago period.

For the full year, our Zacks Consensus Estimates are projecting earnings of -$2.82 per share and revenue of $1.13 billion, which would represent changes of -2.17% and +83.6%, respectively, from the prior year.

Investors might also notice recent changes to analyst estimates for DKNG. These revisions typically reflect the latest short-term business trends, which can change frequently. As a result, we can interpret positive estimate revisions as a good sign for the company’s business outlook.

Based on our research, we believe these estimate revisions are directly related to near-team stock moves. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.

The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. The Zacks Consensus EPS estimate remained stagnant within the past month. DKNG is currently a Zacks Rank #3 (Hold).

The Gaming industry is part of the Consumer Discretionary sector. This industry currently has a Zacks Industry Rank of 110, which puts it in the top 44% of all 250+ industries.

The Zacks Industry Rank includes is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

To follow DKNG in the coming trading sessions, be sure to utilize Zacks.com.

BYD – Boyd Gaming (BYD) Stock Sinks As Market Gains: What You Should Know

In the latest trading session, Boyd Gaming (BYD Free Report) closed at $56.18, marking a -0.09% move from the previous day. This move lagged the S&P 500’s daily gain of 1.02%.

Heading into today, shares of the casino operator had lost 8.52% over the past month, lagging the Consumer Discretionary sector’s loss of 2.13% and the S&P 500’s gain of 3.01% in that time.

BYD will be looking to display strength as it nears its next earnings release, which is expected to be July 27, 2021. In that report, analysts expect BYD to post earnings of $0.88 per share. This would mark year-over-year growth of 189.8%. Meanwhile, our latest consensus estimate is calling for revenue of $770.27 million, up 267.04% from the prior-year quarter.

Looking at the full year, our Zacks Consensus Estimates suggest analysts are expecting earnings of $3.34 per share and revenue of $3.04 billion. These totals would mark changes of +2326.67% and +39.68%, respectively, from last year.

It is also important to note the recent changes to analyst estimates for BYD. These recent revisions tend to reflect the evolving nature of short-term business trends. As such, positive estimate revisions reflect analyst optimism about the company’s business and profitability.

Research indicates that these estimate revisions are directly correlated with near-term share price momentum. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.

The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection has moved 2.81% higher. BYD currently has a Zacks Rank of #1 (Strong Buy).

Investors should also note BYD’s current valuation metrics, including its Forward P/E ratio of 16.82. Its industry sports an average Forward P/E of 25.2, so we one might conclude that BYD is trading at a discount comparatively.

It is also worth noting that BYD currently has a PEG ratio of 0.43. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company’s expected earnings growth rate. The Gaming was holding an average PEG ratio of 1.3 at yesterday’s closing price.

The Gaming industry is part of the Consumer Discretionary sector. This group has a Zacks Industry Rank of 110, putting it in the top 44% of all 250+ industries.

The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.

SCCO – Southern Copper (SCCO) Gains But Lags Market: What You Should Know

In the latest trading session, Southern Copper (SCCO Free Report) closed at $63.08, marking a +0.02% move from the previous day. This change lagged the S&P 500’s 1.02% gain on the day.

Coming into today, shares of the miner had lost 0.93% in the past month. In that same time, the Basic Materials sector gained 1.67%, while the S&P 500 gained 3.01%.

Investors will be hoping for strength from SCCO as it approaches its next earnings release. The company is expected to report EPS of $1.15, up 238.24% from the prior-year quarter. Meanwhile, our latest consensus estimate is calling for revenue of $2.55 billion, up 42.62% from the prior-year quarter.

Looking at the full year, our Zacks Consensus Estimates suggest analysts are expecting earnings of $4.33 per share and revenue of $10.42 billion. These totals would mark changes of +113.3% and +30.45%, respectively, from last year.

Investors should also note any recent changes to analyst estimates for SCCO. These revisions help to show the ever-changing nature of near-term business trends. As such, positive estimate revisions reflect analyst optimism about the company’s business and profitability.

Research indicates that these estimate revisions are directly correlated with near-term share price momentum. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.

The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection has moved 3.71% lower. SCCO is currently sporting a Zacks Rank of #3 (Hold).

Digging into valuation, SCCO currently has a Forward P/E ratio of 14.58. For comparison, its industry has an average Forward P/E of 13.42, which means SCCO is trading at a premium to the group.

It is also worth noting that SCCO currently has a PEG ratio of 0.78. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company’s expected earnings growth rate. Mining – Non Ferrous stocks are, on average, holding a PEG ratio of 0.59 based on yesterday’s closing prices.

The Mining – Non Ferrous industry is part of the Basic Materials sector. This industry currently has a Zacks Industry Rank of 92, which puts it in the top 37% of all 250+ industries.

The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.

DDD – 3D Systems (DDD) Stock Sinks As Market Gains: What You Should Know

In the latest trading session, 3D Systems (DDD Free Report) closed at $25.82, marking a -0.65% move from the previous day. This change lagged the S&P 500’s 1.02% gain on the day.

Coming into today, shares of the maker of 3D printers had lost 31.82% in the past month. In that same time, the Computer and Technology sector gained 1.36%, while the S&P 500 gained 3.01%.

Investors will be hoping for strength from DDD as it approaches its next earnings release, which is expected to be August 9, 2021. The company is expected to report EPS of $0.05, up 138.46% from the prior-year quarter. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $141.93 million, up 26.66% from the year-ago period.

DDD’s full-year Zacks Consensus Estimates are calling for earnings of $0.37 per share and revenue of $586.9 million. These results would represent year-over-year changes of +436.36% and +5.83%, respectively.

Investors might also notice recent changes to analyst estimates for DDD. These recent revisions tend to reflect the evolving nature of short-term business trends. As such, positive estimate revisions reflect analyst optimism about the company’s business and profitability.

Based on our research, we believe these estimate revisions are directly related to near-team stock moves. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.

Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. The Zacks Consensus EPS estimate remained stagnant within the past month. DDD is currently a Zacks Rank #3 (Hold).

Looking at its valuation, DDD is holding a Forward P/E ratio of 71.01. This represents a premium compared to its industry’s average Forward P/E of 18.38.

The Computer – Mini computers industry is part of the Computer and Technology sector. This group has a Zacks Industry Rank of 62, putting it in the top 25% of all 250+ industries.

The Zacks Industry Rank includes is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

Make sure to utilize Zacks. Com to follow all of these stock-moving metrics, and more, in the coming trading sessions.